Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος του γλουταμικού οξέος στην προστασία και λειτουργικότητα του μυοκαρδίου σε εγχειρήσεις στεφανιαίας παράκαμψης
Abstract
dc:descriptionGlutamate is the only amino acid taken up by the human heart in measurable amounts and this uptake is increased in patients with coronary artery disease. Numerous experimental studies have demonstrated that exogenous supply of glutamate improves mechanical function and recovery of ischemic myocardium. A few clinical studies have shown that enrichment of blood cardioplegia with glutamate in patients who undergo a CABG operation with the use of extracorporeal circulation, offers metabolic support to the heart during global ischemia and reperfusion. Till now, it is unknown if pre-bypass supply with glutamate has a protective effect on patients' myocardium who undergo a CABG operation. With present study we tried to investigate the effect of myocardial pre-bypass loading with glutamate on myocardial protection of patients who undergo a CABG operation. Twenty patients who underwent an elective CABG operation were included in present study. Ten patients after anesthesia induction received an infusion of 0,05M L-glutamic acid solution at a rate of 25mg · kgr · BW-1 during one hour period. Another ten patients who served as controls received an equal amount of N/S solution. Intracellular levels of glutamate, ATP and lactate were measured in left ventricular biopsies collected 10min after aortic clamp release. Hemodynamic data, postoperative release of CK-MB and Troponin Τ where also detected. The two groups of patients were comparative in relation to demographic and clinical characteristics and angiographic and operative data. Pre-bypass administration of glutamate resulted in myocardial glutamate loading. Ten min after aortic clamp release glutamate levels were significantly higher in the glutamate group of patients than in controls (18,61 ± 3,14 μg/gr tissue versus 8,73 ± 1,22 μg/gr tissue, p<0,001). In the same group ATP levels were also significantly higher (2,36 ± 0,72 μg/gr tissue versus 1,46 ± 0,35 \μg/gr tissue, p< 0,05) and lactate levels significantly less than in controls (6,92 ± 1,86 μg/gr tissue versus 12,01 ± 2,05 μg/gr tissue, p<0,001). Glutamate group of patients presented better hemodynamic performance than controls. Statistically significant differences were observed on mean CI, LWSI, SVR and PVR. In serial blood samples, CK-MB and Troponin Τ levels were less in glutamate group. Statistically significant differences were observed on mean CK-MB levels at 6th postoperative hour, on total CK-MB value, on peak CK-MB value, on mean troponin Τ levels at 24th postoperative hour, and on total troponin Τ value. In conclusion, pre-bypass intravenous administration of glutamate in patients who undergo a CABG operation has a supportive effect on myocardial metabolism during global ischemia and reperfusion, improves patients postoperative hemodynamic performance and reduces postoperative cardiac enzyme release.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bitzikas, Grigorios
- Μπιτζίκας, Γρηγόριος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/13407